269 related articles for article (PubMed ID: 6436046)
41. Effect of erythroid differentiation factor on maintenance of human hematopoietic cells in co-cultures with allogenic stromal cells.
Nakamura K; Kosaka M; Mizuguchi T; Saito S
Biochem Biophys Res Commun; 1993 Aug; 194(3):1103-10. PubMed ID: 8352765
[TBL] [Abstract][Full Text] [Related]
42. Antigenic characteristics of erythropoietin dependent and independent erythroid progenitors (BFU-E and CFU-E) in polycythaemia vera and idiopathic myelofibrosis defined by monoclonal antibodies.
Robak T
Arch Immunol Ther Exp (Warsz); 1988; 36(6):733-47. PubMed ID: 3254121
[TBL] [Abstract][Full Text] [Related]
43. CFU-GEMM correlate with neutrophil and platelet recovery in patients receiving autologous marrow transplantation after high-dose melphalan chemotherapy.
Roodman GD; LeMaistre CF; Clark GM; Page CP; Newcomb TF; Knight WA
Bone Marrow Transplant; 1987 Aug; 2(2):165-73. PubMed ID: 3332164
[TBL] [Abstract][Full Text] [Related]
44. Blockade of the in vitro effects of testosterone and erythropoietin on Cfu-E and Bfu-E proliferation by pretreatment of the donor rats with cyproterone and flutamide.
Malgor LA; Valsecia M; Vergés E; De Markowsky EE
Acta Physiol Pharmacol Ther Latinoam; 1998; 48(2):99-105. PubMed ID: 9695882
[TBL] [Abstract][Full Text] [Related]
45. In vitro sensitivity of human hematopoietic progenitor cells to 4-hydroperoxycyclophosphamide.
Ratajczak MZ; Ratajczak J; Kuczynski W; Light B; Lusk EJ; Gewirtz AM
Exp Hematol; 1993 Dec; 21(13):1663-7. PubMed ID: 8243568
[TBL] [Abstract][Full Text] [Related]
46. Two classes of primitive pluripotent hemopoietic progenitor cells: separation by adherence.
Kerk DK; Henry EA; Eaves AC; Eaves CJ
J Cell Physiol; 1985 Oct; 125(1):127-34. PubMed ID: 4044666
[TBL] [Abstract][Full Text] [Related]
47. Characterization and quantitation of primitive hematopoietic progenitor cells present in peripheral blood autografts.
Tong J; Hoffman R; Siena S; Srour EF; Bregni M; Gianni AM
Exp Hematol; 1994 Sep; 22(10):1016-24. PubMed ID: 8088376
[TBL] [Abstract][Full Text] [Related]
48. Expression of adhesion molecules on human hematopoietic progenitor cells at different maturational stages.
Kobayashi M; Imamura M; Uede T; Sakurada K; Maeda S; Iwasaki H; Tsuda Y; Musashi M; Miyazaki T
Stem Cells; 1994 May; 12(3):316-21. PubMed ID: 7521241
[TBL] [Abstract][Full Text] [Related]
49. Effects of recombinant human interferon gamma on hematopoietic progenitor cell growth.
Toretsky JA; Shahidi NT; Finlay JL
Exp Hematol; 1986 Mar; 14(3):182-6. PubMed ID: 3081359
[TBL] [Abstract][Full Text] [Related]
50. In vivo modulation of myelopoiesis by prostaglandin E2. II. Inhibition of granulocyte-monocyte progenitor cell (CFU-GM) cell-cycle rate.
Gentile PS; Pelus LM
Exp Hematol; 1987 Feb; 15(2):119-26. PubMed ID: 3469103
[TBL] [Abstract][Full Text] [Related]
51. Modulation of the activity of a human granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein (pIXY 321) by the macrocyclic lactone protein kinase C activator bryostatin 1.
McCrady CW; Li F; Pettit GR; Grant S
Exp Hematol; 1993 Jul; 21(7):893-900. PubMed ID: 7686503
[TBL] [Abstract][Full Text] [Related]
52. Analysis of human hemopoietic progenitor cells for the expression of glycoprotein IIIa.
Kanz L; Mielke R; Fauser AA
Exp Hematol; 1988 Oct; 16(9):741-7. PubMed ID: 3169157
[TBL] [Abstract][Full Text] [Related]
53. Relationship between HLA-DR expression by normal myeloid progenitor cells and inhibition of colony growth by prostaglandin E. Implications for prostaglandin E resistance in chronic myeloid leukemia.
Cannistra SA; Herrmann F; Davis R; Nichols K; Griffin JD
J Clin Invest; 1986 Jan; 77(1):13-20. PubMed ID: 3455931
[TBL] [Abstract][Full Text] [Related]
54. Minor histocompatibility antigen H-Y is expressed on human hematopoietic progenitor cells.
Voogt PJ; Goulmy E; Fibbe WE; Veenhof WF; Brand A; Falkenburg JH
J Clin Invest; 1988 Sep; 82(3):906-12. PubMed ID: 3262125
[TBL] [Abstract][Full Text] [Related]
55. Specificity of heme for hemopoietic recovery from AZT toxicity.
Loewy G; Cook P; Ahmed T; Lutton JD; Nishimura M; Distenfeld A; Levere RD; Abraham NG
Hematol Pathol; 1992; 6(2):79-85. PubMed ID: 1607343
[TBL] [Abstract][Full Text] [Related]
56. Effect of human cytomegalovirus on proliferation of hematopoietic progenitor cells of cord blood.
Liu WJ; Jin RM; Fu XD; Liu B; Guo QL; Deng ZH
Zhongguo Dang Dai Er Ke Za Zhi; 2006 Apr; 8(2):85-9. PubMed ID: 16613695
[TBL] [Abstract][Full Text] [Related]
57. Effect of recombinant human stem cell factor on mafosfamide-treated bone marrow clonogenic cells.
Carlo-Stella C; Mangoni L; Almici C; Caramatti C; Rizzoli V
Stem Cells; 1993 Jul; 11 Suppl 2():170-4. PubMed ID: 7691323
[TBL] [Abstract][Full Text] [Related]
58. Expression of CD11, CDw15, and transferrin receptor antigens on human hematopoietic progenitor cells.
Falkenburg JH; Koning F; Duinkerken N; Fibbe WE; Voogt PJ; Jansen J
Exp Hematol; 1986 Feb; 14(2):90-6. PubMed ID: 3002833
[TBL] [Abstract][Full Text] [Related]
59. Effects of recombinant cytokines on colony formation by irradiated human cord blood CD34+ hematopoietic progenitor cells.
Goff JP; Shields DS; Boggs SS; Greenberger JS
Radiat Res; 1997 Jan; 147(1):61-9. PubMed ID: 8989371
[TBL] [Abstract][Full Text] [Related]
60. Characterization of a two-signal-dependent, Ia+ mononuclear phagocyte progenitor subpopulation that is sensitive to inhibition by ferritin.
Moore RN; Joshi JG; Deana DG; Pitruzzello FJ; Horohov DW; Rouse BT
J Immunol; 1986 Mar; 136(5):1605-11. PubMed ID: 3456388
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
